Recent advances in the management of chronic heart failure

Current Opinion in Cardiology

Volumn 27, Issue 2, 2012, Pages 161-168

  Haddad, Haissam ^a   Mielniczuk, Lisa ^a   Davies, Ross A ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

cardiac resynchronization therapy; heart failure; telemonitoring

Indexed keywords

ALDOSTERONE ANTAGONIST; BISOPROLOL; CARDIOVASCULAR AGENT; EPLERINONE; IVABRADINE; SPIRONOLACTONE; UNCLASSIFIED DRUG;

CARDIAC RESYNCHRONIZATION THERAPY; HEALTH CARE COST; HEART FAILURE; HEART RATE; HUMAN; HYPERKALEMIA; PRIORITY JOURNAL; REVIEW; SYSTOLIC HEART FAILURE; TELEMEDICINE; TELEMONITORING; TREATMENT OUTCOME;

ALDOSTERONE ANTAGONISTS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR AGENTS; DISEASE MANAGEMENT; DISEASE PROGRESSION; HEART FAILURE; HUMANS; TELEMEDICINE; TREATMENT OUTCOME;

EID: 84857036974     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32834fdc98     Document Type: Review

References (15)

1. Rouleau JL. New and emerging drugs and device therapies for chronic heart failure in patients with systolic ventricular dysfunction. Can J Cardiol 2011; 27:296-301.
2. Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006; 22:23-45.
3. Dickstein K, Vardas PE, Auricchio A, et al. Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010; 31:2677-2687.
4. Tang AS, Wells GA, Talajic M, et al. Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild to moderate heart failure. N Engl J Med 2010; 363:2385-2395.
5. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-1549. (Pubitemid 40517094)
6. Pitt B, Zannad F, Remme WJ, et al. Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341:709-717. (Pubitemid 29407370)
7. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348:1309-1321. (Pubitemid 36384098)
8. Zannad F, McMurray JJ, Krum H, et al. EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011; 364:11-21.
9. Fox K, Ford I, Steg PG, et al. Ferrari R on behalf of the BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomized controlled trial. Lancet 2008; 372:817-821.
10. Lechat P, Hulot JS, Escolano S, et al., on behalf of the CIBIS II Investigators. Heart rate and cardiac rhythm relationships with bisoprolol. Benefit in chronic heart failure in CIBIS II Trial. Circulation 2001; 103:1428-1433. (Pubitemid 32220636)
11. Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomized placebo-controlled study. Lancet 2010; 376:875-885.
12. Ekman I, Chassany O, Komajda M, et al. Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: Results from the SHIFT study. Eur Heart J 2011; 32:2395-2404.
13. Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet 2011; 378:731-739.
14. Chaudhry S, Mattera J, Curtis J, et al. Telemonitoring in patients with heart failure. N Engl J Med 2010; 363: 2301-2309.
15. Inglis SC, Clark RA, McAlister FA, et al. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail 2011; 13:1028-1040.